Infliximab drug and antibody levels in patients with dermatological conditions
Crossref DOI link: https://doi.org/10.1007/s11096-014-0062-3
Published Online: 2015-01-23
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Elberdín, L.
Outeda, M.
Salvador, P.
Paradela, S.
Fernández-Torres, R. M.
Iglesias, R.
Fonseca, E.
Martín, I.
Text and Data Mining valid from 2015-01-23